#Autologous Fat Grafting Market Forecast Autologous Fat Grafting Market Size Autologous Fat Grafting Market Trends Autologous Fat Grafting Ma
Text
Autologous Fat Grafting Market Size, Trend, Strategy Analysis & Overview 2027
The Global Autologous Fat Grafting Market 2020 report delivers a fundamental overview of the industry, including definitions, segmentation, applications and industry chain structure analysis. The global autologous fat grafting market report provides competitive landscape analysis, major trends, and key regional development status. It also offers a competitive framework for major revenue-contributing firms covering company market shares with comprehensive profiles. The report provides a key overview of the market status of autologous fat grafting manufacturers with market size, share, growth, market expansion, and technological innovations, as well as the industry cost structure.
Access sample report https://www.factomarketinsights.com/sample/602
It provides the impact and recovery of Covid-19 pandemic on the autologous fat grafting market. Relevant statistical data is also provided in the report to recognize the challenges caused by the outbreak of Covid-19 and strategies to cope up with the current scenario.
The Following are the Key Features of Global Autologous Fat Grafting Market Report:
Market Overview, Industry Development, Market Maturity, PESTLE Analysis, Value Chain Analysis
Growth Drivers and Barriers, Market Trends & Market Opportunities
Porter’s Five Forces Analysis & Trade Analysis
Market Forecast Analysis for 2020-2027
Market Segments by Geographies and Countries
Market Segment Trend and Forecast
Market Analysis and Recommendations
Price Analysis
Key Market Driving Factors
Autologous Fat Grafting Market Company Analysis: Company Market Share & Market Positioning, Company Profiling, Recent Industry Developments etc.
Market Segmentation:
The segmentation of autologous fat grafting market is as follows By Product Type, Application Type, End User. Both developed and developing regions are extensively studied in the report.
Autologous Fat Grafting Market, by Product Type:
Liposuction Systems
Integrated Fat Transfer Systems
Fat Processing Systems
De-Epithelialization Devices
Accessories
Autologous Fat Grafting Market, by Application Type:
Breast Augmentation
Buttock Augmentation
Facial Fat Grafting
Hand rejuvenation
Others
Autologous Fat Grafting Market, by End User:
Hospitals
On-Site Clinics
Plastic Surgery Centers
The regional segmentation of the market covers following regions: North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa (GCC, North Africa, South Africa, and Rest of Middle East & Africa).
Access full report with all information @ https://www.factomarketinsights.com/report/602/autologous-fat-grafting-market
Fundamental Coverage of the Autologous Fat Grafting Market:
Covid-19 impact and strategies to recover.
valuable information about the autologous fat grafting market
Identification of growth in various segments and sub segments of the studied market.
Strategic ideas for investment opportunities
Key statistical data along with products, price analysis, applications, levels of production and consumption, supply and demand.
Emerging developments in the existing market segment and research to help investors devise new business strategies
Accelerates decision-making by drivers and constraints
Competitive Analysis
The key players of the market are listed in this section of the study. It helps to understand the tactics and alliances that players concentrate on fighting market rivalry. An essential microscopic look at the market is given in the detailed study. The key players profiled in the report include
Allergan plc.
Sisram Medical
Black Tie Medical
HK Surgical Inc
MicroAire Surgical Instruments
Labtician Ophthalmics
Proteal Biogenerative Solutions
The GID Group
Lipogems International SpA
Cytori Therapeutics
Genesis Biosystems
Ranfac Corp
Human Med AG
Sterimedix Ltd
Innovia Medical Inc
Inquiry More about This Report @ https://www.factomarketinsights.com/enquiry/602
About Us:
Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on industries, companies, products, and trends.
Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.
Contact Us:
Facto Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 250-1215
Email:[email protected]
Website: www.factomarketinsights.com
0 notes
Text
Autologous fat grafting Market Will Generate New Growth Opportunities in the next 5 year
Autologous fat grafting market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 699.96 million and will grow at a CAGR of 8.62% in the above mentioned forecast period.
Request Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-autologous-fat-grafting-market
The autologous fat grafting market is expected to witness significant growth due to growing preference for the use of non invasive aesthetic techniques in skin rejuvenation. In addition, the various advantages of fat grafting procedures, counting rapid recovery with lesser allergic risks and reduced downtime are also contributing to rising in the global market. Also the celebrity support have been significantly instrumental in alleviating the social stigma adjoining cosmetic procedures is the key factor affecting autologous fat grafting market trends over the forecast period of 2021 to 2028. Additionally, with technological advancements enhancing availability of fat grafting procedures to cover a wider customer base are also responsible for the development of autologous fat grafting market over the forecast period. Furthermore, the constant advances made in approaches and techniques of harvesting, particularly with respect to choice of donor site and wetting solutions is also exceedingly influencing the growth of the autologous fat grafting market.
Global Autologous Fat Grafting Market Scope and Market Size
Autologous fat grafting market is segmented on the basis of product type, application and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
On the basis of product type, the autologous fat grafting market is segmented into integrated fat transfer systems, aspiration and harvesting systems, liposuction systems, fat processing systems, de-epithelialization devices and accessories. Accessories have further been segmented into fat injection cannulas, fat harvesting cannulas, luerlok infiltrator cannulas, cannula connectors & single use fat transfer and tubing sets.
Based on application, the autologous fat grafting market is segmented into breast augmentation, buttock augmentation, facial fat grafting, hand rejuvenation and others.
The end users segment of the autologous fat grafting market is segmented into hospitals, on-site clinics, plastic surgery centers and others.
Request for TOC https://www.databridgemarketresearch.com/toc/?dbmr=global-autologous-fat-grafting-market
Autologous Fat Grafting Market Country Level Analysis
Autologous fat grafting market is analyzed and market size insights and trends are provided by country, product type, application and end users as referenced above.
The countries covered in the autologous fat grafting market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
Inquiry Before Buy @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-autologous-fat-grafting-market
Competitive Landscape and Autologous Fat Grafting Market Share Analysis
Autologous fat grafting market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to autologous fat grafting market.
The major players covered in the autologous fat grafting market report are Allergan, Cytori Therapeutics, Inc., Sisram Medical Ltd, Integra LifeSciences, Genesis Biosystems, Inc, Tulip Medical, Ranfac Corp, HK Surgical Inc, Human Med AG, Emory Healthcare, 3M, MicroAire Surgical Instruments, LLC, Sterimedix Ltd, Alma Lasers, Innovia Medical, Stanford Health Care, Chadda Surgicals, Medikan International Inc., The GID Group and Lipogems International S.p.A., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
0 notes
Text
Analysis of Potential Impact of COVID-19 on Soft Tissue Market
Soft Tissue Market: Introduction
According to the report, the global soft tissue market was valued at US$ 4.3 Mn in 2020 and is projected to expand at a CAGR of ~7% from 2021 to 2031. Soft tissue refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. Soft tissue allograft is used in ACL repair, joint reconstruction in the knee & ankle, meniscal replacement, reconstruction due to cancer or trauma, ridge augmentation in dental procedures, shoulder repair, spinal fusion, and urological procedures. Different types of soft tissue allografts used for surgical procedure are cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The global soft tissue market is driven by better quality alternatives to autografts and technological advancements.
Request a Sample of Soft Tissue Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82408
North America dominated the global soft tissue market in 2020 and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early adoption of new products, high prevalence rate of ACL surgeries, and presence of major players are expected to propel the soft tissue market in North America. Asia Pacific is likely to be a highly lucrative market for soft tissue during the forecast period. The market in the region is projected to expand at a high CAGR from 2021 to 2031.
Request a PDF Brochure- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82408
Better Quality Alternative to Autografts, Technological Advancements to Drive Global Market
Increase in usage of allograft and better alternative to autografts are anticipated to boost the growth of the global soft tissue market. Allograft efficacy in improving stability and function comparable to reconstruction with autologous tissue makes these better alternative to autografts. Soft tissue allografts are more biocompatible than synthetic products, reducing the rates of graft rejection. In an allograft procedure, donor site morbidity is avoided. Additionally, the procedure has benefits such as reduced hospital stay & cost and availability of a range of better quality alternatives to autografts with desired size and shape. Technological advancement is a major factor driving the demand for soft tissue products. Grafts made using dCELL technology give a patient a receptive scaffold that supports cell migration during the natural healing process, while maintaining appropriate tissue strength. PASCO2 technology, developed by Alamo Tissue Service, uses supercritical carbon-dioxide to extract unwanted compounds from soft tissue allografts.
Enquiry before Buying Soft Tissue Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=82408
Collagen Allografts to Dominate Soft Tissue Market
In terms of product type, the global soft tissue market has been classified into cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The tendon allografts segment has been split into Achilles tendon, patellar tendon, and others. The ligament allografts segment has been bifurcated into anterior cruciate ligament and medial collateral ligament. The collagen allografts segment dominated the global soft tissue market in 2020 and the trend is expected to continue during the forecast period.
The rise in the number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Moreover, usage of collagen allografts in maxillofacial surgery and wound care therapies is projected to drive the segment during the forecast period. Dental allografts was the second largest segment in terms of market share in 2020. Increase in regional import of surgical and dental allografts, allograft substitutes, and other acellular dermal matrix is likely to boost the segment.
Hospitals held Significant Market Share
In terms of end user, the global soft tissue market has been divided into hospitals, orthopedic clinics, and others. The hospitals segment led the global soft tissue market in terms of revenue in 2020 and the trend is projected to continue during the forecast period. Hospitalization for orthopedic surgeries and diabetic foot ulcers is anticipated to propel the hospitals segment. Moreover, increase in usage of soft tissue allografts for the treatment of burns and wound management contributes to the segment’s large market share. The segment is also driven by surge in number of surgeries and hospital facilities across the world.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82408
North America to Dominate Soft Tissue Market
In terms of region, the global soft tissue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global soft tissue market in 2020, followed by Europe. North America’s large market share can be ascribed to technologically advanced research and treatment platforms, rise in anterior cruciate ligament injuries, new product launches, and presence of major players. The soft tissue market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2031. This can be ascribed to developing countries being commercial hubs, expanding business organizations, rising awareness about soft tissue allografts, improving healthcare infrastructure, and increasing investments by companies.
Buy now Soft Tissue Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=82408<ype=S
Competition Landscape of Soft Tissue Market
The global soft tissue market is fragmented due to the presence of a large number of players. Key players operating in the global market include Corneat Vision, LinkoCare Life Sciences AB, Presbia plc, Bone Bank Allografts, MTF Biologics, CONMED Corporation, AlloSource, Arthrex, Inc., Zimmer Biomet Holdings, Inc., and RTI Surgical, Inc.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html
https://www.prnewswire.com/news-releases/intravascular-ultrasound-ivus-devices-market-gains-from-rise-in-diagnosis-of-complex-cto-lesions-finds-tmr-301361488.html
https://www.prnewswire.com/news-releases/continuous-innovations-in-surgical-robotics-to-expand-outlook-of-minimally-invasive-surgery-market-global-market-valuation-to-exceed-us-23-6-bn-by-2031--notes-tmr-study-301367220.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
0 notes
Link
This report provides complete information about the worldwide market of Autologous Fat Grafting. Inside, you’ll find the latest information on market models, trends, progress in production and value, and applications, as well as global exchange.
0 notes
Text
Autologous Fat Grafting market Size will Grow by CAGR ~14% through 2019 to 2029
The new report on the Autologous Fat Grafting market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2014 – 2018. ~14% CAGR has been projected for the autologous fat grafting market over 2019-2029, which is prominently estimated to be driven by the increasing social acceptance of aesthetic cosmetic procedures. The business intelligence study offers readers a granular assessment of key growth dynamics, promising avenues, and the competitive landscape of the Autologous Fat Grafting market.
To offer a comprehensive assessment of opportunities, the study makes a scrutiny of growth prospects in various regions. The key regions comprise the following geographical segments:
• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
• Europe (Germany, Italy, France, U.K., Spain, Benelux, Russia, Rest of Europe)
• East Asia (China, Japan, South Korea)
• South Asia & Oceania (India, Thailand, Indonesia, Malaysia, Australia & New Zealand, Rest of South Asia & Oceania)
• Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa, Rest of Middle East & Africa)
The detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas. Taking the analysis further, the study helps readers get a better understanding of the trends characteristics of the emerging markets, including government regulations crucial to growth of such markets. Shares of major regional markets are also presented in the analysis.
The study provides detailed profile of key players and their offering in the Autologous Fat Grafting market, which include
· Sterimedix Ltd,
· Allergan plc.
· the GID Group, INC
· Genesis Biosystems, Inc.
· HK Surgical Inc.
· Black Tie Medical Inc. (Tulip Medical Inc.)
· Human Med AG
· Lipogems International SpA
· Genesis Biosystems, Inc
· Ranfac Corp
· Others
The report offers insight into the competitive dynamic in the Autologous Fat Grafting market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player. The key factors that shape the entry barrier and intensity of competition in the Autologous Fat Grafting market are presented in the analysis. Further, the study provides Pestle analyses of numerous players and an evaluation of how the competitive landscape will evolve over the forecast period.
On the basis of end use industry, the global Autologous Fat Grafting market report offers insights into the opportunities and new avenues of following key segments:
Hospitals
On-Site Clinic
Plastic Surgery Centers
In order to analyze growth prospects in aforementioned segments in the global Autologous Fat Grafting market, the study assesses demand and consumption patterns of following Application segments
Integrated Fat Transfer System
Aspiration and harvesting System
Liposuction System
Fat Processing System
De-Epithelialization
Accessories
The global Autologous Fat Grafting market report answers numerous pertinent questions, some of which are:
What are some of the latent areas of investments in the Autologous Fat Grafting market?
Which region is expected to emerge as showing the most attractive growth rate during the forecast period and which factors will be crucial to its growth?
What trends are likely to change the status quo of the positions held by leading players of the Autologous Fat Grafting market in the not-so-distant future?
Which product/service/technology segments holds game-changing potential to dramatically shape the competitive dynamic in the Autologous Fat Grafting market?
What are the strategies adopted by top players to retain their stronghold in the Autologous Fat Grafting market?
Which strategic moves will new entrants adopt to gain a strong foothold in the Autologous Fat Grafting market?
How can Fact.MR Make Difference?
In-depth understanding of key industry trends shaping the present growth dynamics
Offers value chain analysis and price trend analysis of various offering of competitors
Offers data-drive decision to help companies decide strategies that need recalibration
Offers insights into areas in research and development that should attract
Identifies data outliers before your competitors
0 notes
Text
Facial Fat Transfer Market Competitive Analysis by Recent Trends, Industry Size, Share, Revenue and Foreseen by 2022
Global Facial Fat Transfer Market: Information by Target Area (Naso-Labial Folds, Lips, Marionette Folds, Temples, Chin, Under-Eye Area), Treatment (Dermal Fillers, Fat Injection, Others), End-User (Hospitals, Cosmetic Surgery Clinics, Others) and Region (North America, Europe, Asia-Pacific & Middle East & Africa) - Forecast till 2025
Aging is a longstanding problem faced by women since years, which has resulted in the development of various counter measures. Recently, the loss of facial volume has been recognized as a key underlying cause of aging. Thus, facial fat transfer, a minimally invasive cosmetic procedure, has gained prominence in recent years. It is a method of grafting the face by boosting its volume. Fat from elsewhere of the body is transferred to the face to restore its lost volume. Facial fat transfer helps o correct sagging jaws, hollows under the yes, repair the nasolabial folds and marionette lines. Market Research Future (MRFR) has recently launched a report on the Global Facial Fat Transfer Market Cost and has projected the market to reach a valuation of USD 4.20 Bn at a steady CAGR by the end of the forecast period of 2017-2022.
Growing influence of social media, films, celebrities, and others have evoked the urge in people to look flawless. Changing standards of beauty and fashion has resulted in people trying to defy age and fat transfer is an infallibly convenient treatment as it is readily bio-compatible and accepted by the body. Facial fat transfer is being highly demanded by consumers as they help to create a natural look without much side effects. Development i techniques such as liposuction and others have made fat collection convenient and help to deliver better outcomes. Facial fat transfer procedures are highly sought after by celebrities. With a greater number of men desiring to opt for such cosmetic procedures, the global facial fat transfer market is poised for future increment. Rise in disposable income and towering awareness regarding such procedures is also boosting the growth of the market.
On the other hand, the growth of the market might be hindered by high cost associated with the procedures and the lack of skilled plastic surgeons. Moreover, facial fat transfer being an elective procedure, insurance companies do not cover the procedure for reimbursement, which can hinder the growth of the market over the forecast period.
Competitive Landscape
Galderma S.A., SciVision Biotech Inc., Merz Pharma, Sinclair Pharma, Integra LifeSciences Corporation, ALLERGAN, Valeant, and Sanofi are the key players in the global facial fat transfer market.
Segmentation
The facial fat transfer market has been segmented based on type and treatment.
By type, the facial fat transfer market has been segmented into microlipo injection, autologous fat transfer, and others. By treatment type, the facial fat transfer market has been segmented into fat injections, dermal fillers, and others.
Browse More Information @ https://www.marketresearchfuture.com/reports/thoracolumbar-spine-devices-market-5657
Regional Analysis
Region-wise, the facial transfer market has been segmented into North America, Rest-of-the-World (RoW), Europe, and Asia Pacific (APAC).
North America is the largest facial fat transfer market. North America is known for embracing all latest technologies in the healthcare sector and is a step ahead of other regions in cosmetic surgery. Facial fat transfer is highly popular in the region, especially among celebrities. Affordability quotient and high level of awareness of facial fat transfer procedure is driving the growth of the market. Moreover, the North American region houses some of the best and sought after plastic surgeons of the world and has a developed healthcare infrastructure, which is supporting the growth of the facial fat transfer market.
Europe is expected to be the fastest-growing facial fat transfer market. Towering demand for cosmetic procedures is expected to boost the growth of the market over the forecast period.
The APAC facial fat transfer market is likely to exhibit remarkable growth and emerge as a lucrative market in the coming years. The region is establishing itself as a medical tourism hub and the demand for advanced cosmetic procedures is increasing sharply in the region. Growing availability of skilled cosmetic surgeons, consumers increasingly seeking such treatments, and expanding healthcare sector is providing favorable grounds for the growth of the market.
0 notes
Text
North America is Anticipated to Remain the Leading Market for Autologous Fat Grafting
The global autologous fat grafting market reached ~US$ 317 Mn in 2018 and is anticipated grow at a CAGR of 14% over the forecast period 2019-2029. In this autologous fat grafting market study, the following years are considered to predict the market footprint:
History Year: 2014 - 2018
Base Year: 2018
Estimated Year: 2029
Forecast Year: 2019 – 2029
The business intelligence study of the autologous fat grafting market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the autologous fat grafting market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the autologous fat grafting market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:
North America (U.S., Canada)
Latin America (Argentina, Brazil)
Europe (Germany, France)
Japan
APEJ (China, India)
The key players in the global autologous fat grafting market report consist of
Lipogems International SpA
The GID Group, INC
Medikan International Inc
Proteal Biogenerative Solutions.
Innovia Medical Inc
Labtician Ophthalmics, Inc
Sterimedix Ltd
MicroAire Surgical Instruments, LLC
HK Surgical Inc
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2701
Each market player encompassed in the autologous fat grafting market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the autologous fat grafting market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.
On the basis of product type, the global autologous fat grafting market report covers the footprint, and consumption of the segments including
Integrated Fat Transfer Systems
Aspiration and Harvesting Systems
Liposuction Systems
Fat Processing Systems
De-Epithelialization Devices
The global autologous fat grafting market covers the demand trends of each end user which includes
Hospitals
On-Site Clinics
Plastic Surgery Centers
What insights readers can gather from the autologous fat grafting market report?
A critical study of the autologous fat grafting market on the basis of product, application and end user.
Learn the behavior pattern of every autologous fat grafting market player – product launches, expansions, collaborations and acquisitions in the market currently.
Examine and study the progress outlook of the global autologous fat grafting market landscape, which includes, revenue, production & consumption and historical & forecast.
Understand important drivers, restraints, opportunities, and trends (DROT Analysis).
Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization.
The autologous fat grafting market report answers the following queries:
Which players hold the significant autologous fat grafting market share and why?
What strategies are the autologous fat grafting market players forming to gain a competitive edge?
Why region is expected to lead the global autologous fat grafting market?
What factors are negatively affecting the autologous fat grafting market growth?
What will be the value of the global autologous fat grafting market by the end of 2029?
Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2701
Why Choose Fact.MR?
Deliver updated information on the current industry trends
Available 24/7 to facilitate clients with unbiased solutions
Embrace digital technologies to offer accurate business ideas
Exhaustive supply chain augmentation analysis
Provide reports strictly according to the requirements of the clients
0 notes
Text
Europe Platelet-Rich Plasma Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026
Platelet-rich plasma, also known as autologous conditioned plasma, is a concentrate of platelet-rich plasma protein derived from whole blood, centrifuged to remove red blood cells. Europe platelet-rich plasma market includes market size for platelet-rich plasma systems and platelet-rich plasma kits.
The market report includes Europe platelet-rich plasma market value analysis by product type, applications, end user and country.
Europe platelet-rich plasma market holds huge growth potential and is expected to expand at 9.2% CAGR over 2019-2026.
PRP Systems
Platelet-rich plasma systems included in this report are centrifuge systems specifically for separation of platelet-rich plasma and platelet poor plasma from autologous blood samples drawn at the point-of-care facility.
Other centrifuge systems which have application in other cellular therapies and preparation of substances derived from body fluids are excluded from the scope of this report
Examples of PRP systems included in this report are GPS® III Platelet Concentration System (Zimmer Biomet), The Arthrex ACP® Double Syringe System (Arthrex Inc), Arthrex Angel® cPRP Processing System (Arthrex Inc.) etc. among others
PRP Kits
PRP kits considered in this segment of the report include PRP preparation kits and PRP harvest kits. PRP Kit that makes Platelet-Rich Plasma extractions simple and cost-efficient
PRP preparation and harvest kits generally include PRP Tubes, Re-Suspension Tube, injectors, needles, phlebotomy sets etc.
PRP kits are made available to end users through three prominent sales channels. Sales channels included in this report are Direct Sales Channels, Distributor Sale Channels, and Others (group purchasing organisations, wholesalers, pharmacists etc.)
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=136&page=requestsample
Market Dynamics:
· Sales Channel
Being low margin product, direct sales channel sub-segment of PRP kits product type is the most popular
· End User
All clinics segments collectively experience high demand for PRP kits in Europe
· Applications
High demand for PRP kits is from cosmetic applications, including Skin rejuvenation, scar treatment, skin firming & whitening, fat grafting, hair loss treatment etc.
In U.K., PRP treatment industry is well established. However, there's limited presence of domestic manufacturers of PRP kits in U.K. Hence, PRP kits are availed in the country through distributors that have partnership with manufacturing companies
Report Structure:
Europe Platelet Rich Plasma Market, by Product Type
· Platelet-rich Plasma Systems
· Kits & consumables (preparation kits, harvesting kits, etc.)
Europe Platelet Rich Plasma Market, by Application
· Cosmetic/Aesthetic/Hair Fall Treatment
· Orthopedics/Rehabilitation medicine
· Dentistry
· Ophthalmology
· Research and Development
· Veterinary
Europe Platelet Rich Plasma Market, End Users
· Physician's office/Private Practice/Veterinary Clinics
· Hospitals
· Orthopedic Clinics
· Cosmetic/dermatology/Trichology Clinics
· Academic & Research Institutes
Europe Platelet Rich Plasma Market, Region
· Germany
· Italy
· France
· U.K.
· Spain
· Rest of the Europe
Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=136&page=askfordiscount
Competitive Landscape:
· Tier 1 players- established companies in the market with major market share
· Tier 2 players
· Emerging players which are growing rapidly
· New Entrants
FutureWise Takeaways
· Growth prospects
· SWOT analysis
· Key trends
· Key datapoints affecting market growth
Objectives of the Study:
· To provide with an exhaustive analysis on Europe platelet rich plasma market by product, application, end-user and region
· To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
· To evaluate and forecast micro-markets and overall market
· To predict market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, and Latin America
· To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
· Profiling of companies to evaluate their market shares, strategies, financials and core competencies
Table of Contents
1. Section 1
1.1. About Us
1.2. Overall Research Process
1.3. Research Methodology
1.4. Report Assumptions and Acronyms
1.5. Forecasting Factors and Assumptions
2. Section 2
2.1. Market Purview
2.1.1. Report Description
2.1.2. Market Definition and Scope
2.2. Executive Summary: Platelet-rich Plasma Market
2.2.1. Top 3 Market Findings
2.2.2. Top 3 Market Opportunity
2.2.3. Market Snippet By Region/Country
2.2.4. Market Snippet By Product Type
2.2.5. Market Snippet By Applications
2.3. Coherent Opportunity Map (COM)
3. Section 3
3.1. Market Dynamics, Regulations, and Trends Analysis
3.1.1. Market Dynamics
3.1.1.1. Drivers
3.1.1.1.1. Supply Side Drivers
3.1.1.1.2. Demand Side Drivers
3.1.1.1.3. Economic Drivers
3.1.1.2. Restraints
3.1.1.3. Market Opportunities
3.1.1.4. Key Trends
3.2. Porter’s Five Force Analysis: New Product Launch Perspective
3.3. Products Application Analysis
3.4. U.K. Platelet-Rich Plasma Market End User Analysis
4. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By Product Type
4.1. Key Findings
4.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Product Type (2019 ^ 2026)
4.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Product Type
4.3.1. Platelet-Rich Plasma Systems
4.3.2. PRP Kits & Consumables
4.3.2.1. Direct Sales
4.3.2.2. Distributor Sales
4.3.2.3. Group Purchasing Organizations
4.4. Long Term ROI Segments, By Product Type
5. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By Application
5.1. Key Findings
5.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Application (2019 & 2026)
5.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Applications
5.3.1. Dermatology/Plastic Surgery
5.3.2. Orthopedics/Rehabilitation medicine
5.3.3. Dentistry
5.3.4. Ophthalmology
5.3.5. Research and Development
5.3.6. Veterinary
5.4. Long Term ROI Segments, By Applications
6. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By End User
6.1. Key Findings
6.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By End Users
6.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By End Users
6.3.1. Physician's office/Private Practice
6.3.2. Hospitals
6.3.3. Orthopedic Clinics
6.3.4. Cosmetic/dermatology/Trichology Clinics
6.3.5. Academic & Research Institutes
6.4. Long Term ROI Segments, By End Users
7. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019 – 2026, By Country
7.1. Introduction & Key Findings
7.2. Europe Platelet-rich Plasma Market Value Share and Y-o-Y Analysis, By Country
7.3. Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis and Forecast 2019-2026, By Country
7.3.1. Germany
7.3.2. Italy
7.3.3. France
7.3.4. U.K.
7.3.5. Spain
7.3.6. Rest of the Europe
7.4. Long Term ROI Segments, By Region
8. Germany Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
8.1. Key Findings
8.2. Germany Platelet-rich Plasma Market Value Share Analysis
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.3.1. Platelet-Rich Plasma Systems
8.3.2. PRP Kits & Consumables
8.3.2.1. Direct Sales
8.3.2.2. Distributor Sales
8.3.2.3. Group Purchasing Organizations
8.4. Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.4.1. Dermatology/Plastic Surgery
8.4.2. Orthopedics/Rehabilitation medicine
8.4.3. Dentistry
8.4.4. Ophthalmology
8.4.5. Research and Development
8.4.6. Veterinary
8.5. End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
8.5.1. Physician's office/Private Practice
8.5.2. Hospitals
8.5.3. Orthopedic Clinics
8.5.4. Cosmetic/dermatology/Trichology Clinics
8.5.5. Academic & Research Institutes
8.6. Germany Platelet-rich Plasma Market Trends
9. Italy Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
9.1. Key Findings
9.2. Italy Platelet-rich Plasma Market Value Share Analysis
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.3.1. Platelet-Rich Plasma Systems
9.3.2. PRP Kits & Consumables
9.3.2.1. Direct Sales
9.3.2.2. Distributor Sales
9.3.2.3. Group Purchasing Organizations
9.4. Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.4.1. Dermatology/Plastic Surgery
9.4.2. Orthopedics/Rehabilitation medicine
9.4.3. Dentistry
9.4.4. Ophthalmology
9.4.5. Research and Development
9.4.6. Veterinary
9.5. End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
9.5.1. Physician's office/Private Practice
9.5.2. Hospitals
9.5.3. Orthopedic Clinics
9.5.4. Cosmetic/dermatology/Trichology Clinics
9.5.5. Academic & Research Institutes
9.6. Italy Platelet-rich Plasma Market Trends
10. France Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
10.1.Key Findings
10.2.France Platelet-rich Plasma Market Value Share Analysis
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.3.1. Platelet-Rich Plasma Systems
10.3.2. PRP Kits & Consumables
10.3.2.1. Direct Sales
10.3.2.2. Distributor Sales
10.3.2.3. Group Purchasing Organizations
10.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.4.1. Dermatology/Plastic Surgery
10.4.2. Orthopedics/Rehabilitation medicine
10.4.3. Dentistry
10.4.4. Ophthalmology
10.4.5. Research and Development
10.4.6. Veterinary
10.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
10.5.1. Physician's office/Private Practice
10.5.2. Hospitals
10.5.3. Orthopedic Clinics
10.5.4. Cosmetic/dermatology/Trichology Clinics
10.5.5. Academic & Research Institutes
10.6.France Platelet-rich Plasma Market Trends
11. U.K. Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
11.1.Key Findings
11.2.U.K. Platelet-rich Plasma Market Value Share Analysis
11.2.1. By Product Type
11.2.2. By Application
11.2.3. By End User
11.2.4. By Country
11.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.3.1. Platelet-Rich Plasma Systems
11.3.2. PRP Kits & Consumables
11.3.2.1. Direct Sales
11.3.2.2. Distributor Sales
11.3.2.3. Group Purchasing Organizations
11.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.4.1. Dermatology/Plastic Surgery
11.4.2. Orthopedics/Rehabilitation medicine
11.4.3. Dentistry
11.4.4. Ophthalmology
11.4.5. Research and Development
11.4.6. Veterinary
11.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
11.5.1. Physician's office/Private Practice
11.5.2. Hospitals
11.5.3. Orthopedic Clinics
11.5.4. Cosmetic/dermatology/Trichology Clinics
11.5.5. Academic & Research Institutes
11.6.U.K. Platelet-rich Plasma Market Trends
12. Spain Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
12.1.Key Findings
12.2.Spain Platelet-rich Plasma Market Value Share Analysis
12.2.1. By Product Type
12.2.2. By Application
12.2.3. By End User
12.2.4. By Country
12.3.Product Type Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.3.1. Platelet-Rich Plasma Systems
12.3.2. PRP Kits & Consumables
12.3.2.1. Direct Sales
12.3.2.2. Distributor Sales
12.3.2.3. Group Purchasing Organizations
12.4.Application Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.4.1. Dermatology/Plastic Surgery
12.4.2. Orthopedics/Rehabilitation medicine
12.4.3. Dentistry
12.4.4. Ophthalmology
12.4.5. Research and Development
12.4.6. Veterinary
12.5.End User Revenue (USD Mn), Y-o-Y Growth (%) Analysis and Forecast
12.5.1. Physician's office/Private Practice
12.5.2. Hospitals
12.5.3. Orthopedic Clinics
12.5.4. Cosmetic/dermatology/Trichology Clinics
12.5.5. Academic & Research Institutes
12.6.Spain Platelet-rich Plasma Market Trends
13. Rest of the Europe Platelet-rich Plasma Market Revenue (USD Mn) Analysis, 2019–2026
13.1.Key Findings
13.2.Rest of the Europe Platelet-rich Plasma Market Value Share Analysis
13.2.1. By Product Type
13.2.2. By Application
13.2.3. By End User
13.2.4. By Country
13.2.5. Rest of the Europe stitutes
13.3.Market Influencing Factors
14. Europe Platelet-rich Plasma Market Competition
14.1.Competition Dashboard
14.2.Competitive Landscape
14.2.1. Key Development Strategies
14.2.2. Market Tier Structure Analysis
14.2.3. Competitors Concentration, By Region
14.3.Platelet-rich Plasma Product Life Cycle Positioning
14.4.Company Profiles
14.4.1. Terumo BCT
14.4.1.1. Overview
14.4.1.2. Product Portfolio
14.4.1.3. Financial Performance
14.4.1.4. Peer Comparison & 3C marketing equation
14.4.1.5. Company Strategy & Channel Management
14.4.2. Zimmer Biomet
14.4.2.1. Overview
14.4.2.2. Product Portfolio
14.4.2.3. Financial Performance
14.4.2.4. Peer Comparison & 3C marketing equation
14.4.2.5. Company Strategy & Channel Management
14.4.3. NeoGenesis Co. Ltd
14.4.3.1. Overview
14.4.3.2. Product Portfolio
14.4.3.3. Financial Performance
14.4.3.4. Peer Comparison & 3C marketing equation
14.4.3.5. Company Strategy & Channel Management
14.4.4. Glofinn oy Overview
14.4.4.1. Product Portfolio
14.4.4.2. Financial Performance
14.4.4.3. Peer Comparison & 3C marketing equation
14.4.4.4. Company Strategy & Channel Management
14.4.5. T Biotechnology (T Lab)
14.4.5.1. Overview
14.4.5.2. Product Portfolio
14.4.5.3. Financial Performance
14.4.5.4. Peer Comparison & 3C marketing equation
14.4.5.5. Company Strategy & Channel Management
14.4.6. Regen Lab SA
14.4.6.1. Overview
14.4.6.2. Product Portfolio
14.4.6.3. Financial Performance
14.4.6.4. Peer Comparison & 3C marketing equation
14.4.6.5. Company Strategy & Channel Management
14.4.7. SDD Medical Group Ltd Overview
14.4.7.1. Product Portfolio
14.4.7.2. Financial Performance
14.4.7.3. Peer Comparison & 3C marketing equation
14.4.7.4. Company Strategy & Channel Management
14.4.8. IntraVita International Limited Overview
14.4.8.1. Product Portfolio
14.4.8.2. Financial Performance
14.4.8.3. Peer Comparison & 3C marketing equation
14.4.8.4. Company Strategy & Channel Management
14.4.9. Exactech Inc.
14.4.9.1. Overview
14.4.9.2. Product Portfolio
14.4.9.3. Financial Performance
14.4.9.4. Peer Comparison & 3C marketing equation
14.4.9.5. Company Strategy & Channel Management
14.4.10. Arthrex Inc.
14.4.10.1. Overview
14.4.10.2. Product Portfolio
14.4.10.3. Financial Performance
14.4.10.4. Peer Comparison & 3C marketing equation
14.4.10.5. Company Strategy & Channel Management
14.4.11. Biotechnology Institute (bti)
14.4.11.1. Overview
14.4.11.2. Product Portfolio
14.4.11.3. Financial Performance
14.4.11.4. Peer Comparison & 3C marketing equation
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
0 notes
Text
Avascular Necrosis Market Insights Report 2018 - Research and Markets
The global avascular necrosis market size was valued at US$ 512.9 million in 2017, and is expected to witness a CAGR of 6.0% over the forecast period (2018 – 2026).
Avascular necrosis (AVN) also termed as osteonecrosis, or aseptic necrosis, or ischemic bone necrosis, a condition resulting in the death of bone cells due to loss of blood supply. It often leads to collapse of the joint surface and subsequent arthritis due to an irregular joint surface. Avascular necrosis affects the ends (epiphysis) of long bones such as femur, upper humerus, and bones of ankle joint. Usually it develops due to combination of various factors including metabolic, genetic, increased alcohol consumption, smoking, and other diseases.
An X-ray is generally used to diagnose cause of joint pain. However, magnetic resonance imaging (MRI), is the most sensitive method for diagnosing avascular necrosis in early stages. Unlike X-rays, bone scans, and computed/computerized tomography (CT) scans, MRI detects chemical changes in bone marrow and shows avascular necrosis in its earliest stages.
Nonsurgical treatment options for avascular necrosis such as anti-inflammatory medications, activity changes, and crutches can help relieve pain and slow progression of the disease. Surgical treatment include core decompression, bone and cartilage grafting, and total hip replacement. Based on the cause, avascular necrosis can be classified as traumatic and non-traumatic avascular necrosis. According to the Science Direct Journal 2010 report, traumatic injury such as ankle sprain, fracture and joint dislocation is the most common cause of AVN, which can occur eight hours after disruption to the blood supply. Non-traumatic avascular necrosis occurs usually at young age and its causes include chronic liver disease, corticosteroids, decompression sickness, fat embolism syndrome, Gaucher disease, gout, hyperlipidaemia, haemoglobinopathy, metabolic bone disease, systemic chemotherapy systemic lupus erythematosus, and alcoholism among others.
Excessive alcohol consumption and long-term, high dose systemic corticosteroid use are the major risk factors for avascular necrosis. According to World Journal of Orthopedics, 2015, avascular necrosis usually affects people between 30 and 50 years of age. Also, from the same source, about 10,000 to 20,000 people develop osteonecrosis each year in the U.S. According to National Organization for Rare Disorders’ 2015 data, alcohol consumption and corticosteroid use affects about 30% and 35% of all people with non-traumatic avascular necrosis, respectively across the globe.
Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2218
Other risk factors or conditions associated with non-traumatic osteonecrosis include autoimmune disease, cancer, decompression disease (Caisson disease), Gaucher disease, pancreatitis, HIV infection, and blood disorders such as sickle cell disease. Certain medical treatments including radiation therapy and chemotherapy can also cause osteonecrosis. Moreover, people who have undergone organ transplants are at high developmental risk of osteonecrosis.
Technological advancement in therapies for avascular necrosis such as Advanced Therapy Medicinal Products (ATMPs) is expected to boost avascular necrosis market. Advanced Therapy Medicinal Products is a class of innovative therapies that comprises of gene therapy, somatic cell therapy, and tissue-engineered products.
Avascular Necrosis Market Restraints
High cost of surgical treatments and delay in diagnosis due to asymptomatic nature of this condition at early stage are the major restraining factors for avascular necrosis market growth. For instance, according to Blue Cross Blue Shield of North Carolina, a total hip replacement procedure usually cost between US$ 31,839 and US$ 44,816, with an average cost of US$ 39,299.
Avascular Necrosis Market - Regional Insights
On the basis of region, the global avascular necrosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to generate a significant revenue share in global avascular necrosis market during the forecast period due to increasing prevalence of avascular necrosis and prior Food and Drug Administration (FDA) approval for the new avascular necrosis treatments in the region. For instance, according to National Center for Biotechnology Information (NCBI), 2015, about 20,000 to 30,000 new patients are diagnosed with avascular necrosis every year in the U.S.
Asia Pacific avascular necrosis market is expected to foresee highest growth rate during the forecast period, owing to increase in development activities for the treatment of avascular necrosis by various key players in this region. For instance, in 2017, Asahi Kasei Corporation and Bone Therapeutics signed a license agreement for the development and commercialization of PREOB in Japan. PREOB is an autologous osteoblastic cell therapy product derived from ex vivo cultured bone marrow cells of the patients.
Click To Reading More On Avascular Necrosis Market
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]
Visit our news Website: https://www.coherentwire.com
0 notes
Text
Soft Tissue Market is Booming Worldwide According to New Research Report
Soft Tissue Market: Introduction
According to the report, the global soft tissue market was valued at US$ 4.3 Mn in 2020 and is projected to expand at a CAGR of ~7% from 2021 to 2031. Soft tissue refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. Soft tissue allograft is used in ACL repair, joint reconstruction in the knee & ankle, meniscal replacement, reconstruction due to cancer or trauma, ridge augmentation in dental procedures, shoulder repair, spinal fusion, and urological procedures. Different types of soft tissue allografts used for surgical procedure are cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The global soft tissue market is driven by better quality alternatives to autografts and technological advancements.
Request a Sample of Soft Tissue Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82408
North America dominated the global soft tissue market in 2020 and the trend is anticipated to continue during the forecast period. Highly structured healthcare industry, early adoption of new products, high prevalence rate of ACL surgeries, and presence of major players are expected to propel the soft tissue market in North America. Asia Pacific is likely to be a highly lucrative market for soft tissue during the forecast period. The market in the region is projected to expand at a high CAGR from 2021 to 2031.
Request a PDF Brochure- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82408
Better Quality Alternative to Autografts, Technological Advancements to Drive Global Market
Increase in usage of allograft and better alternative to autografts are anticipated to boost the growth of the global soft tissue market. Allograft efficacy in improving stability and function comparable to reconstruction with autologous tissue makes these better alternative to autografts. Soft tissue allografts are more biocompatible than synthetic products, reducing the rates of graft rejection. In an allograft procedure, donor site morbidity is avoided. Additionally, the procedure has benefits such as reduced hospital stay & cost and availability of a range of better quality alternatives to autografts with desired size and shape. Technological advancement is a major factor driving the demand for soft tissue products. Grafts made using dCELL technology give a patient a receptive scaffold that supports cell migration during the natural healing process, while maintaining appropriate tissue strength. PASCO2 technology, developed by Alamo Tissue Service, uses supercritical carbon-dioxide to extract unwanted compounds from soft tissue allografts.
Enquiry before Buying Soft Tissue Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=82408
Collagen Allografts to Dominate Soft Tissue Market
In terms of product type, the global soft tissue market has been classified into cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The tendon allografts segment has been split into Achilles tendon, patellar tendon, and others. The ligament allografts segment has been bifurcated into anterior cruciate ligament and medial collateral ligament. The collagen allografts segment dominated the global soft tissue market in 2020 and the trend is expected to continue during the forecast period.
The rise in the number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Moreover, usage of collagen allografts in maxillofacial surgery and wound care therapies is projected to drive the segment during the forecast period. Dental allografts was the second largest segment in terms of market share in 2020. Increase in regional import of surgical and dental allografts, allograft substitutes, and other acellular dermal matrix is likely to boost the segment.
Hospitals held Significant Market Share
In terms of end user, the global soft tissue market has been divided into hospitals, orthopedic clinics, and others. The hospitals segment led the global soft tissue market in terms of revenue in 2020 and the trend is projected to continue during the forecast period. Hospitalization for orthopedic surgeries and diabetic foot ulcers is anticipated to propel the hospitals segment. Moreover, increase in usage of soft tissue allografts for the treatment of burns and wound management contributes to the segment’s large market share. The segment is also driven by surge in number of surgeries and hospital facilities across the world.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82408
North America to Dominate Soft Tissue Market
In terms of region, the global soft tissue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global soft tissue market in 2020, followed by Europe. North America’s large market share can be ascribed to technologically advanced research and treatment platforms, rise in anterior cruciate ligament injuries, new product launches, and presence of major players. The soft tissue market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2031. This can be ascribed to developing countries being commercial hubs, expanding business organizations, rising awareness about soft tissue allografts, improving healthcare infrastructure, and increasing investments by companies.
Buy now Soft Tissue Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=82408<ype=S
Competition Landscape of Soft Tissue Market
The global soft tissue market is fragmented due to the presence of a large number of players. Key players operating in the global market include Corneat Vision, LinkoCare Life Sciences AB, Presbia plc, Bone Bank Allografts, MTF Biologics, CONMED Corporation, AlloSource, Arthrex, Inc., Zimmer Biomet Holdings, Inc., and RTI Surgical, Inc.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html
https://www.prnewswire.com/news-releases/intravascular-ultrasound-ivus-devices-market-gains-from-rise-in-diagnosis-of-complex-cto-lesions-finds-tmr-301361488.html
https://www.prnewswire.com/news-releases/continuous-innovations-in-surgical-robotics-to-expand-outlook-of-minimally-invasive-surgery-market-global-market-valuation-to-exceed-us-23-6-bn-by-2031--notes-tmr-study-301367220.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
0 notes
Text
Autologous Fat Grafting Market Global Segments, Top Key Players, Size and Recent Trends by Forecast to 2029
The study opines that increasing traction of autologous fat grafting as a promising method for breast augmentation, continues to expand the bandwidth of opportunities for the stakeholders in the development of products and accessories. Gains from autologous fat grafting used for breast augmentation will account for ~50% market shares in 2019.
Request for the Report Summary: https://www.factmr.com/report/2701/autologous-fat-grafting-market
Autologous fat grafting is emerging as a promising and safer alternative to breast augmentation procedures. Key players in the market are leveraging mergers and acquisitions based strategies to gain a strong hold in the market. For instance, in June 2019, Innova Medical partnered with Medical Device Resource Corporation to present their plastic and cosmetic surgery customers with holistic and diverse autologous fat grafting product options.
Sensing varied requirements of autologous fat grafting procedure, a range of products have been developed and introduced to the market, which range from accessories and integrated fat transfer systems, to fat processing systems. Demand for accessories continue to grow at a relatively faster rate, with sales estimated to account for ~60% shares in 2019 and the foreseeable future. Fat harvesting cannulas will remain the top-selling accessory of autologous fat grafting, with sales estimated to record ~20% Y-o-Y in 2019 over 2018.
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2701
According to the study, North America will remain the leading market for autologous fat grafting, accounting for ~40% share in 2019. Favorable reimbursement policies apropos of the dermatology procedures and aesthetic medicine continue to augur well for growth of the autologous fat grafting market in North America. Promising areas of research in the autologous fat grafting have come to the fore, with targeted experiments on tissue engineering constructs, ASC culture and expansion, converging with the clinical reconstructive processes.
Growing adoption of integrated fat transfer systems to remove local deposits of excess fat via minimal incision, and for transferring the tissue back to the patient, have significantly driven the demand for integrated fat transfer systems. Additionally, there has been a notable rise in the use of liposuction systems in autologous fat grafting, owing to their ability to effectively reduce surgeon fatigue, while offering a safer and more precise solution that results in faster recovery for patients.
Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2701
About Us
Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.
Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.
The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.
Contact Us
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: [email protected]
Blog: https://theheraldmedia.com/
0 notes
Text
Autologous Fat Grafting Market Trends, Research, Analysis & Forecast 2019 -2029 Major Growth By Top Competitors
The study opines that increasing traction of autologous fat grafting as a promising method for breast augmentation, continues to expand the bandwidth of opportunities for the stakeholders in the development of products and accessories. Gains from autologous fat grafting used for breast augmentation will account for ~50% market shares in 2019.
Request for the Report Summary: https://www.factmr.com/report/2701/autologous-fat-grafting-market
Autologous fat grafting is emerging as a promising and safer alternative to breast augmentation procedures. Key players in the market are leveraging mergers and acquisitions based strategies to gain a strong hold in the market. For instance, in June 2019, Innova Medical partnered with Medical Device Resource Corporation to present their plastic and cosmetic surgery customers with holistic and diverse autologous fat grafting product options.
Sensing varied requirements of autologous fat grafting procedure, a range of products have been developed and introduced to the market, which range from accessories and integrated fat transfer systems, to fat processing systems. Demand for accessories continue to grow at a relatively faster rate, with sales estimated to account for ~60% shares in 2019 and the foreseeable future. Fat harvesting cannulas will remain the top-selling accessory of autologous fat grafting, with sales estimated to record ~20% Y-o-Y in 2019 over 2018.
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2701
According to the study, North America will remain the leading market for autologous fat grafting, accounting for ~40% share in 2019. Favorable reimbursement policies apropos of the dermatology procedures and aesthetic medicine continue to augur well for growth of the autologous fat grafting market in North America. Promising areas of research in the autologous fat grafting have come to the fore, with targeted experiments on tissue engineering constructs, ASC culture and expansion, converging with the clinical reconstructive processes.
Growing adoption of integrated fat transfer systems to remove local deposits of excess fat via minimal incision, and for transferring the tissue back to the patient, have significantly driven the demand for integrated fat transfer systems. Additionally, there has been a notable rise in the use of liposuction systems in autologous fat grafting, owing to their ability to effectively reduce surgeon fatigue, while offering a safer and more precise solution that results in faster recovery for patients.
Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2701
About Us
Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level – our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.
Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.
The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.
Contact Us
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
E: [email protected]
Blog: https://theheraldmedia.com/
0 notes
Last Seen Blogs
kaitex
Kaite_xyxy
schwarzer-huf
schwarzer Huf
jonathansherman
Untitled
claimchange
Making Life Easier
renae-the-turtle
The Remaker